REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 212 filers reported holding REATA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $248,000 | -8.5% | 2,464 | +28.7% | 0.02% | -10.7% |
Q2 2021 | $271,000 | -40.3% | 1,914 | -47.8% | 0.03% | -54.1% |
Q4 2020 | $454,000 | +46.0% | 3,669 | +15.1% | 0.06% | +27.1% |
Q3 2020 | $311,000 | -34.5% | 3,189 | +4.8% | 0.05% | -45.5% |
Q2 2020 | $475,000 | +17.6% | 3,043 | +8.7% | 0.09% | -20.0% |
Q1 2020 | $404,000 | – | 2,800 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DekaBank Deutsche Girozentrale | 17,000 | $2,930 | 0.01% |
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 93,711 | $1,612 | 0.00% |
IFP Advisors, Inc | 300 | $51,708 | 0.00% |